The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with type 2 diabetes and chronic kidney ...

Ozempic injection pens have several strengths: 2 mg per 3 milliliters (mL), 2 mg/1.5 mL, 4 mg/3 mL, and 8 mg/3 mL. Each pen ...

Novo Nordisk’s (NVO) weight-loss drug, which shares an active ingredient with Ozempic ... pen that the drug typically comes in, at a cheaper price. A four-week supply of the 2.5 mg Zepbound ...